Home page  |  About this library  |  Help  |  Clear       English  |  French  |  Spanish  
Expand Document
Expand Chapter
Full TOC
Preferences
to previous section to next section

close this bookGuidelines for the Treatment of Malaria (WHO; 2006; 266 pages) View the PDF document
View the documentGlossary
View the documentAbbreviations
open this folder and view contents1. Introduction
View the document2. The clinical disease
open this folder and view contents3. Treatment objectives
open this folder and view contents4. Diagnosis of malaria
open this folder and view contents5. Resistance to antimalarial medicines9
open this folder and view contents6. Antimalarial treatment policy
open this folder and view contents7. Treatment of uncomplicated P. Falciparum malaria10
open this folder and view contents8. Treatment of severe falciparum malaria14
close this folder9. Treatment of malaria caused by P. vivax, P. ovale or P. malariae19
View the document9.1 Diagnosis
View the document9.2 Susceptibility of P. vivax, P. ovale and P. malariae to antimalarials
View the document9.3 Treatment of uncomplicated vivax malaria
View the document9.4 Treatment of severe vivax malaria
View the document9.5 Treatment of malaria caused by P. ovale and P. malariae
View the document9.6 Monitoring therapeutic efficacy for vivax malaria
View the document10. Mixed malaria infections
open this folder and view contents11. Complex emergencies and epidemics
open this folder and view contentsAnnexes
 

9.1 Diagnosis

The clinical features of uncomplicated malaria are too non-specific for a clinical diagnosis of the species of malaria infection to be made. Diagnosis of P. vivax malaria is based on microscopy. Although rapid diagnostic tests based on immunochromatographic methods are available for the detection of non-falciparum malaria, their sensitivities below parasite densities of 500/┬Ál are low. Their relatively high cost is a further impediment to their wide use in endemic areas. Molecular markers for genotyping P. vivax parasites have been developed to assist epidemiological and treatment studies but these are still under evaluation.

to previous section to next section

Please provide your feedback   English  |  French  |  Spanish